Skip to main content

Neurofibromatosis Type 1

Shacara Wilson, MD and Michael G Niederbrach, MD Reviewed 04/2024
 


BASICS

DESCRIPTION

  • Neurofibromatosis types 1 (NF1) and 2 (NF2) are neurocutaneous syndromes (phakomatoses). Although they share a name, they are unrelated.

    • NF1, the most common of the phakomatoses, is a...

DIAGNOSIS

  • NF1 is a clinical diagnosis based on the NIH criteria and the Revised diagnostic criteria. A diagnosis usually can be made through routine exam, usually by age 4 with special attention to sk...

TREATMENT

GENERAL MEASURES

While there are no curative treatments for NF1, treatment should focus on the symptoms and secondary disease processes for which patients with NF1 are at higher risk, e.g., H...

ONGOING CARE

FOLLOW-UP RECOMMENDATIONS

NF1 health supervision 2008 guidelines: 
  • Infancy to 1 year

    • Growth and development: mild short stature, macrocephaly (increased brain volume); aqueductal stenosis/ob...

REFERENCES

1
Gutmann DH, Ferner RE, Listernick RH, et al. Neurofibromatosis Type 1. Nat Rev Dis Primers. 2017;3:17004. doi: 10.1038/nrdp.2017.4.
2
Legius E, Messiaen L, Wolkenstain P, et al.; Internation...

SEE ALSO

Tuberous Sclerosis Complex; Von Hippel-Lindau Syndrome 

CODES

ICD10

Q85.01 Neurofibromatosis, type 1 

SNOMED

  • 92824003 neurofibromatosis, type 1 (disorder)

  • 403815003 Axillary freckling due to neurofibromatosis (disorder)

  • 403816002 multiple caf-au-lait macules du...

CLINICAL PEARLS

  • NF1 manifests marked clinical variability. External stigmata may be subtle or absent in young children. Minimally affected children may become severely affected adults.

  • A single CALM is...

Subscribe to Access Full Content

Sign Up for a 10-Day Free Trial

Sign up for a 10-day FREE Trial now and receive full access to all content.

 
×